CC BY-NC-ND 4.0 · South Asian J Cancer 2022; 11(03): 183-189
DOI: 10.1055/s-0042-1743420
Original Article
Breast Cancer

Quality of Life Post Breast Cancer Surgery: Comparison of Breast Conservation Surgery versus Modified Radical Mastectomy in a Developing Country

Kurian Cherian
1   Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India
,
Nitish Rajan Acharya
1   Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India
,
Rexeena V. Bhargavan
1   Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India
,
1   Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India
,
1   Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India
› Author Affiliations
 

Abstract

Introduction Breast cancer survivors are the largest group of female cancer survivors. Oncologic breast surgery can have a profound impact on a woman's body image and sense of self that can significantly affect their quality of life (QOL). The paucity of data about the effect of type of surgery on QOL of Indian breast cancer survivors has led to this study.

Materials and Methods This prospective study included consecutive female early breast cancer patients who underwent primary surgery, that is, breast conservation surgery (BCS) or modified radical mastectomy (MRM) from January 1, 2015 to December 31, 2015. The primary objective was the comparison of QOL using European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and EORTC QLQ-BR 23 between the two groups at 6 months and 1 year postsurgery with the baseline.

Results One hundred and thirty-eight patients were included of which 62 underwent BCS and 76 underwent MRM. BCS patients fared better with respect to physical functioning, dyspnea, fatigue, appetite loss, and body image at 6 months (p < 0.05) as compared with MRM. At 1 year postsurgery, BCS patients fared better with respect to physical functioning, role functioning, global health status, body image, sexual enjoyment, and dyspnea, while MRM patients fared better in emotional functioning and future prospectives (p < 0.05).

Conclusion Patients undergoing BCS have a better QOL with respect to various functional and symptom scales at 6 months and 1 year. However, patients undergoing MRM perform better in terms of future perspective and emotional functioning at 1 year.


#

Introduction

Zoom Image
Kurian Cherian

Breast conservation surgery (BCS) is now a well-established alternative to modified radical mastectomy (MRM).[1] [2] [3] Twenty-year follow-up of these patients has shown equivalent survival.[1] [2] [3] Multidisciplinary management has improved the overall survival of breast cancer patients in all stages. Women with a history of breast cancer are the largest group of female cancer survivors and account for ∼41% of the total.[4] The earlier stage at diagnosis and the use of multimodality therapy have improved the likelihood of long-term disease-free survivorship.

Oncologic breast surgery can have a profound impact on a woman's body image and sense of self. To date, the relative impact of these various surgical therapies on patients' satisfaction and quality of life (QOL) remains unclear. Most studies have analyzed populations in the developed countries, which may differ substantially from those in less developed geographic regions. Indian women differ in ethnic, social, cultural as well as economical aspects as compared with Western women. There is little data available about treatment preferences among Indian women, whose wishes regarding cosmetic results or other factors may differ from those in the West. The data available are contradictory with some studies showing worse QOL in BCS patients in India.[5] A recent systematic review shows discordance in QOL with respect to the type of surgery in Asian patients.[6] The paucity of data regarding the QOL issues after breast cancer surgery in the Indian population in spite of the heavy disease burden has led to this study.


#

Materials and Methods

This is a prospective study performed in the Department of Surgical Services, Regional Cancer Center, Thiruvananthapuram, Kerala, India. This study was conducted after Institutional Review Board and Ethics Committee clearance. The duration of the study was from January 1, 2015, to December 31, 2015. Women with pathologically proven early breast carcinoma undergoing primary MRM or BCS were recruited for the study. Pregnant or lactating women and women with bilateral breast cancers were excluded from the study. The primary objective of the study was to compare the QOL between patients undergoing BCS and MRM at baseline, 6 months, and 1 year postsurgery period. For a power of 80%, an α error of 5%, and a β error of 20%, a sample size of 138 was calculated.

Written informed consent was obtained from all patients. The validated Malayalam version7 of the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the QLQ-BR23 was filled by all the participants, immediate presurgery, 6 months postsurgery, and 1 year postsurgery. Data was entered using SPSS software, Version SPSS 11.0.1, (LEAD Technologies, Inc., Charlotte, North Carolina, United States of America) and scored as per the scoring manual. Categorical variables were summarized using frequencies and its corresponding percentages. The continuous variables were expressed in terms of mean and standard deviation. The independent sample t-test was used to compare postsurgery 6 months and 1 year with baseline. p-Value < 0.05 was considered to be statistically significant.


#

Results

One hundred and thirty-eight patients were included in the study. Sixty-two patients underwent BCS and 76 patients MRM. None of the patients underwent any reconstructive procedure. The patient characteristics are summarized in [Table 1]. The median age of patients undergoing BCS was 43 years (range: 34–71 years), while that of patients undergoing MRM was 52 years (range: 33–69 years). All patients underwent level I, II, and III clearance. Most of the patients presented in stage II in both the arms. Stage II was also the most common pathological stage. Fifty-one (82%) patients in the BCS arm and 64 patients (84%) in the MRM arm received adjuvant chemotherapy. All patients who underwent BCS received adjuvant radiotherapy, whereas 50 patients (66%) who had undergone MRM receive radiotherapy. Endocrine therapy was received by 36 patients (58%) in the BCS arm and 42 patients (55%) in the MRM arm. Both the groups were comparable at baseline (immediate presurgery), at 6 months, and at 1 year, respectively, except for the median age that was a decade younger in the BCS group. [Table 2] depicts the baseline QOL scores of both the groups. Both the groups were well matched at baseline with no significant differences. QOL scores at 6 months are depicted in [Table 3]. BCS patients fared significantly better with respect to functional scales of physical functioning and body image. They also fared better with respect to symptom scales of dyspnea, fatigue, and appetite loss at 6 months postsurgery (p < 0.05) ([Figs. 1],[2],[3]). The QOL scores at 1 year are depicted in [Table 4]. At 1 year postsurgery, BCS patients fared better with respect to physical functioning, role functioning, global health status, body image, sexual enjoyment, and dyspnea, while post-MRM patients fared better in emotional functioning and future prospectives (p < 0.05) ([Table 4]).

Table 1

Patient characteristics

BCS

MRM

Age (y)

31–40

9

4

41–50

30

22

51–60

19

42

61–70

4

8

cT stage

T1

16

8

T2

46

66

T3

0

2

c N stage

N0

37

30

N1

25

46

Final histopathology

Stage I

12

4

Stage II

46

68

Stage III

4

4

Adjuvant chemotherapy

Received

51

64

Not received

11

8

Adjuvant radiotherapy

Received

62

50

Not received

0

26

Endocrine therapy

Received

36

42

Not received

26

34

Abbreviations: BCS, breast conservation surgery; MRM, modified radical mastectomy.


Table 2

Comparison of QOL between BCS and MRM patients at baseline

Scale

Group

Mean

SD

p-Value

EORTC QLQ C30

Functional scales

Physical functioning

BCS

83.55

16.23

0.409

MRM

81.14

17.60

Role functioning

BCS

88.44

19.23

0.094

MRM

82.46

21.92

Emotional functioning

BCS

76.61

22.88

0.950

MRM

76.86

23.59

Cognitive functioning

BCS

86.56

21.94

0.720

MRM

87.72

15.96

Social functioning

BCS

84.14

25.33

0.497

MRM

83.95

18.30

Symptom scales

Dyspnea

BCS

6.45

14.58

0.083

MRM

11.84

21.57

Pain

BCS

11.56

16.96

0.056

MRM

18.42

23.50

Fatigue

BCS

16.67

22.65

0.192

MRM

21.64

21.77

Sleep

BCS

18.28

29.37

0.407

MRM

22.81

33.65

Appetite loss

BCS

11.83

25.68

0.832

MRM

10.96

22.04

Nausea and vomiting

BCS

5.91

15.12

0.854

MRM

6.36

13.32

Constipation

BCS

11.29

23.33

0.935

MRM

10.96

23.34

Diarrhea

BCS

4.30

11.27

0.868

MRM

3.95

13.30

Financial difficulties

BCS

30.11

35.56

0.061

MRM

45.18

45.77

Global health status QOL

BCS

77.15

18.96

0.058

MRM

69.63

17.78

EORTC QLQ BR23

Functional scales

Body image

BCS

91.13

18.72

0.500

MRM

89.14

15.75

Sexual functioning

BCS

75.30

27.52

0.063

MRM

86.03

19.66

Sexual enjoyment

BCS

28.33

36.73

0.066

MRM

17.11

33.77

Future prospective

BCS

58.60

36.56

0.866

MRM

59.65

35.83

Symptoms scales

Systematic therapy side effects

BCS

13.54

15.54

0.162

MRM

17.17

14.67

Arm symptoms

BCS

12.72

16.69

0.337

MRM

15.57

17.73

Breast symptoms

BCS

9.81

13.03

0.264

MRM

12.61

15.72

Hair loss

BCS

15.36

11.47

0.146

MRM

23.77

13.34

Abbreviations: BCS, breast conservation surgery; EORTC QLQ, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire; MRM, modified radical mastectomy; QOL, quality of life; SD, standard deviation.


Table 3

Comparison of QOL between BCS and MRM patients at 6 months

Scale

Group

Mean

SD

p-Value

EORTC QLQ C30

Functional scales

Physical functioning

BCS

62.15

20.41

0.039

MRM

54.56

22.04

Role functioning

BCS

64.52

20.58

0.349

MRM

61.18

20.80

Emotional functioning

BCS

57.93

16.76

0.759

MRM

58.92

20.23

Cognitive functioning

BCS

80.11

18.81

0.351

MRM

76.97

20.18

Social functioning

BCS

41.67

20.85

0.788

MRM

40.57

25.87

Symptom scales

Dyspnea

BCS

15.59

20.66

0.015

MRM

25.88

28.07

Pain

BCS

43.28

19.43

0.583

MRM

45.18

20.69

Fatigue

BCS

41.76

21.07

0.037

MRM

49.34

21.02

Sleep

BCS

34.95

22.12

0.050

MRM

43.42

28.29

Appetite loss

BCS

32.80

21.33

0.032

MRM

41.23

24.26

Nausea and vomiting

BCS

26.08

18.75

0.050

MRM

33.33

23.41

Constipation

BCS

10.75

18.87

0.155

MRM

6.58

14.42

Diarrhea

BCS

12.90

20.34

0.151

MRM

17.98

20.69

Financial difficulties

BCS

68.28

27.28

0.605

MRM

70.61

25.51

Global health status QOL

BCS

54.57

12.77

0.058

MRM

49.78

16.04

EORTC QLQ BR23

Functional scales

Body image

BCS

67.07

20.60

<0.001

MRM

48.36

22.44

Sexual functioning

BCS

95.63

12.13

0.442

MRM

86.03

19.66

Sexual enjoyment

BCS

8.06

26.09

0.666

MRM

6.22

23.69

Future prospective

BCS

37.63

27.98

0.630

MRM

39.91

27.23

Symptoms scales

Systematic therapy side effects

BCS

42.63

12.60

0.315

MRM

44.80

12.59

Arm symptoms

BCS

66.31

20.12

0.429

MRM

69.15

21.59

Breast symptoms

BCS

54.84

19.99

0.558

MRM

52.85

19.61

Hair loss

BCS

65.36

11.47

0.146

MRM

68.85

13.43

Abbreviations: BCS, breast conservation surgery; EORTC QLQ, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire; MRM, modified radical mastectomy; QOL, quality of life; SD, standard deviation.


Zoom Image
Fig. 1 Comparison of breast conservation surgery (BCS) and modified radical mastectomy (MRM) with respect to physical functioning.
Zoom Image
Fig. 2 Comparison of breast conservation surgery (BCS) or modified radical mastectomy (MRM) with respect to fatigue, appetite, dyspnea, and pain.
Zoom Image
Fig. 3 Comparison of breast conservation surgery (BCS) and modified radical mastectomy (MRM) with respect to body image and future prospective.
Table 4

Comparison of QOL between BCS and MRM patients at 1 year

Scale

Group

Mean

SD

p-Value

EORTC QLQ C30

Functional scales

Physical functioning

BCS

76.99

15.91

0.037

MRM

70.53

19.45

Role functioning

BCS

83.06

18.23

0.026

MRM

75.66

19.90

Emotional functioning

BCS

70.43

14.13

0.029

MRM

75.40

12.35

Cognitive functioning

BCS

89.25

14.81

0.057

MRM

83.99

16.87

Social functioning

BCS

56.72

15.23

0.907

MRM

57.02

14.47

Symptom scales

Dyspnea

BCS

3.76

10.64

0.449

MRM

5.26

12.24

Pain

BCS

22.58

16.00

0.537

MRM

24.34

17.09

Fatigue

BCS

21.68

18.04

0.126

MRM

26.61

19.21

Sleep

BCS

15.59

19.76

0.492

MRM

26.61

19.21

Appetite loss

BCS

13.98

19.60

0.151

MRM

18.86

19.88

Nausea and vomiting

BCS

9.14

13.39

0.13

MRM

15.79

17.62

Constipation

BCS

4.30

12.78

0.169

MRM

1.75

7.49

Diarrhea

BCS

3.76

10.64

0.449

MRM

5.26

12.24

Financial difficulties

BCS

54.30

24.32

0.502

MRM

57.02

22.98

Global health status QOL

BCS

73.66

9.92

0.033

MRM

69.63

11.68

EORTC QLQ BR23

Functional scales

Body image

BCS

80.78

21.26

<0.001

MRM

53.51

19.54

Sexual functioning

BCS

97.04

10.24

0.436

MRM

98.41

9.33

Sexual enjoyment

BCS

7.10

22.04

0.024

MRM

69.63

11.68

Future prospective

BCS

40.86

25.90

<0.001

MRM

62.28

22.00

Symptoms scales

Systematic therapy side effects

BCS

28.80

12.97

0.514

MRM

30.08

8.97

Arm symptoms

BCS

65.23

16.89

0.348

MRM

62.57

16.21

Breast symptoms

BCS

41.80

13.28

0.287

MRM

39.04

16.45

Hair loss

BCS

47.85

39.40

0.906

MRM

48.68

42.67

Abbreviations: BCS, breast conservation surgery; EORTC QLQ, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire; MRM, modified radical mastectomy; QOL, quality of life; SD, standard deviation.



#

Discussion

QOL studies are an integral part of the multidisciplinary management of cancer patients. They provide a measure of the wholesome treatment that includes the social, psychological, and emotional aspects of the disease, apart from the physical aspect. QOL measures individual's or group's perceived physical and mental health over time.[7] With the advent of newer treatments, breast cancer patients have an improved overall survival. This raises questions about the QOL in these patients most of who receive multimodality treatment.

Breast surgery has a great impact on all aspects of a woman's life. There are multiple studies on the impact of breast surgery on the QOL in Western population.[8] The spectrum of breast cancer in India is different from that of the West. Patients are about one decade younger in developing countries like India than their counterparts in developed nations.[9] Thus, the QOL issues of Indian women may be different from that of Western women. There are a few studies of QOL in breast cancer patients from Asia with contradictory results. Edib et al observed that women who underwent BCS had better global health status than women who had mastectomy.[10] In contrast, Huang et al found that patients who had BCS had poorer global health status than those who had mastectomy.[11] Other studies comparing BCS and mastectomy did not find associations with global health status[12] [13] [14] [15] or overall well-being.[16] [17] [18] [19]

Our study compares the QOL post-BCS and MRM immediate presurgery, at 6 months after surgery, and at 1 year after surgery. The median age of women in the BCS group was a decade younger than that of the MRM group. Both groups were comparable at baseline. A single-time measure of QOL carries a lesser value as compared with multiple measures over a period of time. Multiple measures help to study the change over time and to effectively compare between treatments. In our study, we have measured the QOL at three different time periods with respect to the surgery of breast cancer using the Malayalam version (local language) of the questionnaires. The same questionnaires were used in a similar Indian study in young breast cancer patients by Dubashi et al.[5]

At 6 months postsurgery, BCS patients fared significantly better with respect to physical functioning, dyspnea, fatigue, appetite loss, and body image when compared with those undergoing MRM. At 1 year postsurgery, BCS patients fared better with respect to physical functioning, role functioning, dyspnea, global health, sexual enjoyment, and body image, while MRM patients fared better in emotional functioning and future prospectives.

The results as per the available literature are variable, with a few studies agreeing with our results, whereas others have pointed to the contrary. Dubashi et al found the QOL and sexual functioning to be marginally worse in the BCS group when compared with mastectomy group.[5] In the study by Pandey et al, women undergoing MRM were found to have significant deterioration in physical and functional well-being, breast-specific subscale, trial outcome index, and overall QOL as compared with BCS.[20] This study looked at a similar population and is in concordance with our study.

In breast cancer survivors, sometimes the only reminder of their malignancy is the mutilating scar on their chest. This logically leads to emotional distress and body image issues in all age groups. Patients undergoing BCS in our study tend to have a better body image of themselves as compared with patients undergoing MRM. An Egyptian study showed that women in MRM group had higher level of body image distress among cognitive, affective, and behavioral aspects.[21] This is in concordance with other literature that has reported better perception of body image in patients undergoing BCS.[22]

Interestingly, in our study, patients undergoing MRM have fared better than their BCS counterparts in terms of future perspective. Many studies have shown future perspective to be worse in MRM patients as compared with BCS patients.[5] [23] [24] Our study results are in contradiction to these studies. The fear of recurrence in the residual breast and the younger age of the BCS group may contribute to such a finding. Numerous trials have proved the oncological similarity between the two procedures.[1] [2] [3] Proper counseling goes a long way in allaying the fears of the patients undergoing breast conservation. Although we counsel our patients about the safety of BCS, probably better counseling is required.

Patients undergoing MRM have also fared better in terms of emotional functioning in our study. In contrast, Enien et al found that BCS patients fared better in emotional functioning compared with those undergoing MRM.[25] Again, the younger age of the BCS patients in our study could contribute to this finding.

There are many drawbacks of our study. No data on sociodemographics and psychosocial factors were available that can have a significant impact on the QOL. The BCS group was a decade younger than the MRM group. This age difference may have contributed to some of the difference in QOL between the two groups. There is no data about the comorbidities that significantly affect the QOL. None of our patients underwent reconstructive surgery. Reconstruction after MRM improves the body image as compared with mastectomy alone.[26] Details regarding ovarian ablation or suppression therapy, type of chemotherapy and impact of radiotherapy in QOL are not available.


#

Conclusions

Patients undergoing BCS fare better than patients undergoing MRM at 6 months and 1 year in terms of physical functioning, role functioning, and global health status. They tend to have a better perception of their body image and perform better in terms of various symptom scales. Patients undergoing MRM, in turn, tend to perform better in terms of future perspective and emotional functioning at 1 year. The choice of breast conservation should be offered to all patients if oncologically safe and cosmetically acceptable in early breast cancer even in developing countries.


#
#

Conflict of Interest

None declared.

Acknowledgments

Nil.

Sources

Nil.


Note

Presented as a poster in the annual meeting of the Association of Radiation Oncologists of India in September 2017.


  • References

  • 1 Fisher B, Anderson S, Bryant J. et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347 (16) 1233-1241
  • 2 Litière S, Werutsky G, Fentiman IS. et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012; 13 (04) 412-419
  • 3 Veronesi U, Cascinelli N, Mariani L. et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347 (16) 1227-1232
  • 4 NCI Office of Cancer Survivorship. Accessed January 4, 2021 from: http://cancercontrol.cancer.gov/ocs/prevalence/chart2.html
  • 5 Dubashi B, Vidhubala E, Cyriac S, Sagar TG. Quality of life among younger women with breast cancer: study from a tertiary cancer institute in south India. Indian J Cancer 2010; 47 (02) 142-147
  • 6 Ho PJ, Gernaat SAM, Hartman M, Verkooijen HM. Health-related quality of life in Asian patients with breast cancer: a systematic review. BMJ Open 2018; 8 (04) e020512 DOI: 10.1136/bmjopen-2017-020512.
  • 7 Centre for Disease Control and prevention. http://www.cdc.gov/chronicdisease/stats/index.htm . Accessed January 4, 2021
  • 8 Rietman JS, Dijkstra PU, Hoekstra HJ. et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003; 29 (03) 229-238
  • 9 Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg 2007; 31 (05) 1031-1040
  • 10 Edib Z, Kumarasamy V, Binti Abdullah N, Rizal AM, Al-Dubai SA. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outcomes 2016; 14: 26
  • 11 Huang CC, Lien HH, Tu SH. et al. Quality of life in Taiwanese breast cancer survivors with breast-conserving therapy. J Formos Med Assoc 2010; 109 (07) 493-502
  • 12 Kao HY, Wu WH, Liang TY, Lee KT, Hou MF, Shi HY. Cloud-based service information system for evaluating quality of life after breast cancer surgery. PLoS One 2015; 10 (09) e0139252
  • 13 Shi HY, Uen YH, Yen LC, Culbertson R, Juan CH, Hou MF. Two-year quality of life after breast cancer surgery: a comparison of three surgical procedures. Eur J Surg Oncol 2011; 37 (08) 695-702
  • 14 Kim MK, Kim T, Moon HG. et al. Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol 2015; 41 (03) 426-432
  • 15 Sun Y, Kim SW, Heo CY. et al. Comparison of quality of life based on surgical technique in patients with breast cancer. Jpn J Clin Oncol 2014; 44 (01) 22-27
  • 16 He ZY, Tong Q, Wu SG, Li FY, Lin HX, Guan XX. A comparison of quality of life and satisfaction of women with early-stage breast cancer treated with breast conserving therapy vs. mastectomy in southern China. Support Care Cancer 2012; 20 (10) 2441-2449
  • 17 Taira N, Shimozuma K, Ohsumi S. et al. Abstract P4–14–07: Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life two years after breast cancer surgery. Cancer Res 2012; 72: P4–14–07
  • 18 Yan B, Yang LM, Hao LP. et al. Determinants of quality of life for breast cancer patients in Shanghai, China. PLoS One 2016; 11 (04) e0153714
  • 19 Ohsumi S, Shimozuma K, Morita S. et al. Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery. Jpn J Clin Oncol 2009; 39 (08) 491-496
  • 20 Pandey M, Thomas BC, Ramdas K, Ratheesan K. Early effect of surgery on quality of life in women with operable breast cancer. Jpn J Clin Oncol 2006; 36 (07) 468-472
  • 21 Shoma AM, Mohamed MH, Nouman N. et al. Body image disturbance and surgical decision making in Egyptian post menopausal breast cancer patients. World J Surg Oncol 2009; 7: 66 DOI: 10.1186/1477-7819-7-66.
  • 22 Tsai HY, Kuo RN, Chung KP. Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan. Jpn J Clin Oncol 2017; 47 (10) 909-918
  • 23 Zanapalioglu Y, Atahan K, Gur S, Cokmez A, Tarcan E. Effect of breast conserving surgery in quality of life in breast cancer patients. J Breast Health 2009; 152-156
  • 24 Acil H, Cavdar I. Comparison of quality of life of Turkish breast cancer patients receiving breast conserving surgery or modified radical mastectomy. Asian Pac J Cancer Prev 2014; 15 (13) 5377-5381
  • 25 Enien MA, Ibrahim N, Makar W, Darwish D, Gaber M. Health-related quality of life: impact of surgery and treatment modality in breast cancer. J Cancer Res Ther 2018; 14 (05) 957-963
  • 26 Dauplat J, Kwiatkowski F, Rouanet P. et al; STIC-RMI working group. Quality of life after mastectomy with or without immediate breast reconstruction. Br J Surg 2017; 104 (09) 1197-1206

Address for correspondence

Rexeena V. Bhargavan, MCh
Department of Surgical Oncology, Regional Cancer Centre
Thiruvananthapuram, Kerala, 695011
India   

Publication History

Article published online:
25 April 2022

© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Fisher B, Anderson S, Bryant J. et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347 (16) 1233-1241
  • 2 Litière S, Werutsky G, Fentiman IS. et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012; 13 (04) 412-419
  • 3 Veronesi U, Cascinelli N, Mariani L. et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347 (16) 1227-1232
  • 4 NCI Office of Cancer Survivorship. Accessed January 4, 2021 from: http://cancercontrol.cancer.gov/ocs/prevalence/chart2.html
  • 5 Dubashi B, Vidhubala E, Cyriac S, Sagar TG. Quality of life among younger women with breast cancer: study from a tertiary cancer institute in south India. Indian J Cancer 2010; 47 (02) 142-147
  • 6 Ho PJ, Gernaat SAM, Hartman M, Verkooijen HM. Health-related quality of life in Asian patients with breast cancer: a systematic review. BMJ Open 2018; 8 (04) e020512 DOI: 10.1136/bmjopen-2017-020512.
  • 7 Centre for Disease Control and prevention. http://www.cdc.gov/chronicdisease/stats/index.htm . Accessed January 4, 2021
  • 8 Rietman JS, Dijkstra PU, Hoekstra HJ. et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003; 29 (03) 229-238
  • 9 Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg 2007; 31 (05) 1031-1040
  • 10 Edib Z, Kumarasamy V, Binti Abdullah N, Rizal AM, Al-Dubai SA. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outcomes 2016; 14: 26
  • 11 Huang CC, Lien HH, Tu SH. et al. Quality of life in Taiwanese breast cancer survivors with breast-conserving therapy. J Formos Med Assoc 2010; 109 (07) 493-502
  • 12 Kao HY, Wu WH, Liang TY, Lee KT, Hou MF, Shi HY. Cloud-based service information system for evaluating quality of life after breast cancer surgery. PLoS One 2015; 10 (09) e0139252
  • 13 Shi HY, Uen YH, Yen LC, Culbertson R, Juan CH, Hou MF. Two-year quality of life after breast cancer surgery: a comparison of three surgical procedures. Eur J Surg Oncol 2011; 37 (08) 695-702
  • 14 Kim MK, Kim T, Moon HG. et al. Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol 2015; 41 (03) 426-432
  • 15 Sun Y, Kim SW, Heo CY. et al. Comparison of quality of life based on surgical technique in patients with breast cancer. Jpn J Clin Oncol 2014; 44 (01) 22-27
  • 16 He ZY, Tong Q, Wu SG, Li FY, Lin HX, Guan XX. A comparison of quality of life and satisfaction of women with early-stage breast cancer treated with breast conserving therapy vs. mastectomy in southern China. Support Care Cancer 2012; 20 (10) 2441-2449
  • 17 Taira N, Shimozuma K, Ohsumi S. et al. Abstract P4–14–07: Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life two years after breast cancer surgery. Cancer Res 2012; 72: P4–14–07
  • 18 Yan B, Yang LM, Hao LP. et al. Determinants of quality of life for breast cancer patients in Shanghai, China. PLoS One 2016; 11 (04) e0153714
  • 19 Ohsumi S, Shimozuma K, Morita S. et al. Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery. Jpn J Clin Oncol 2009; 39 (08) 491-496
  • 20 Pandey M, Thomas BC, Ramdas K, Ratheesan K. Early effect of surgery on quality of life in women with operable breast cancer. Jpn J Clin Oncol 2006; 36 (07) 468-472
  • 21 Shoma AM, Mohamed MH, Nouman N. et al. Body image disturbance and surgical decision making in Egyptian post menopausal breast cancer patients. World J Surg Oncol 2009; 7: 66 DOI: 10.1186/1477-7819-7-66.
  • 22 Tsai HY, Kuo RN, Chung KP. Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan. Jpn J Clin Oncol 2017; 47 (10) 909-918
  • 23 Zanapalioglu Y, Atahan K, Gur S, Cokmez A, Tarcan E. Effect of breast conserving surgery in quality of life in breast cancer patients. J Breast Health 2009; 152-156
  • 24 Acil H, Cavdar I. Comparison of quality of life of Turkish breast cancer patients receiving breast conserving surgery or modified radical mastectomy. Asian Pac J Cancer Prev 2014; 15 (13) 5377-5381
  • 25 Enien MA, Ibrahim N, Makar W, Darwish D, Gaber M. Health-related quality of life: impact of surgery and treatment modality in breast cancer. J Cancer Res Ther 2018; 14 (05) 957-963
  • 26 Dauplat J, Kwiatkowski F, Rouanet P. et al; STIC-RMI working group. Quality of life after mastectomy with or without immediate breast reconstruction. Br J Surg 2017; 104 (09) 1197-1206

Zoom Image
Kurian Cherian
Zoom Image
Fig. 1 Comparison of breast conservation surgery (BCS) and modified radical mastectomy (MRM) with respect to physical functioning.
Zoom Image
Fig. 2 Comparison of breast conservation surgery (BCS) or modified radical mastectomy (MRM) with respect to fatigue, appetite, dyspnea, and pain.
Zoom Image
Fig. 3 Comparison of breast conservation surgery (BCS) and modified radical mastectomy (MRM) with respect to body image and future prospective.